Related Experiment Video
Updated: Feb 20, 2026

Utilizing Percutaneous Ventricular Assist Devices in Acute Myocardial Infarction Complicated by Cardiogenic Shock
Published on: June 12, 2021
Cardiogenic Shock: A State-of-the-Art Review
Aaron Samuels1, Tetiana Zolotarova2, Mark J Eisenberg3
1Department of Medicine, McGill University, Montreal, Canada.
Insights
Cardiogenic shock care has evolved, with survival improving due to new treatments and standardized classifications. The focus is now on long-term recovery for patients experiencing this critical cardiovascular emergency.
Area of Science:
- Cardiovascular Medicine
- Critical Care Medicine
Background:
- Cardiogenic shock, a severe cardiac dysfunction causing inadequate tissue perfusion, is a critical cardiovascular emergency.
- The etiology of cardiogenic shock has shifted from predominantly ischemic to non-ischemic causes like heart failure over the last two decades.
- Evolving classification systems (SCAI stages, SHOCK-ARCF) aid in standardized diagnosis and risk stratification.
Purpose of the Study:
- To review the evolving landscape of cardiogenic shock management.
- To highlight advancements in diagnosis, risk stratification, and therapeutic strategies.
- To discuss the shift in focus towards long-term survivorship.
Main Methods:
- Review of modern classification systems for diagnosis and risk stratification.
- Analysis of traditional and contemporary management strategies, including pharmacotherapy, revascularization, and mechanical circulatory support.
- Examination of system-level improvements like multidisciplinary shock teams and CICU liberation bundles.
Main Results:
- Standardized classification systems have improved diagnosis and risk stratification.
- Advances in management, including mechanical support and team-based care, have led to decreased in-hospital mortality.
- Early outcomes have improved, prompting a shift towards survivorship.
Conclusions:
- Modern management strategies and system-level improvements have significantly reduced in-hospital mortality for cardiogenic shock.
- The focus of care is transitioning from acute management to addressing the long-term physical, cognitive, and psychological needs of survivors.
- Ensuring meaningful, independent living is the new goal for cardiogenic shock survivorship.
Abstract:
Cardiogenic shock is a state of inadequate tissue perfusion caused by severe cardiac dysfunction, representing a critical emergency in cardiovascular medicine. Over the past two decades, its profile has evolved from being primarily ischemic to increasingly driven by heart failure and other nonischemic etiologies. Modern classification systems, including the Society for Cardiovascular Angiography and Interventions stages and the Shock Academic Research Consortium framework, have standardized diagnosis and improved risk stratification across etiologies. Traditional management relied on pharmacotherapy and early revascularization to restore perfusion, while newer strategies incorporate mechanical circulatory support devices, alongside multidisciplinary shock teams, CICU liberation bundles, and structured family engagement. These therapeutic and system-level advances have contributed to steady declines in in-hospital mortality and improved early outcomes. In conclusion, as survival continues to improve, the focus of cardiogenic shock care is shifting toward survivorship, addressing long-term physical, cognitive, and psychological recovery to ensure that survival translates into meaningful, independent living.
Related Concept Videos
Cardiopulmonary Resuscitation IV: Pharmacological Management
Cardiomyopathy II: Dilated Cardiomyopathy
Introduction Cardiac Emergencies
Blood Pressure Imbalances and Circulatory Shock
Blood Pressure: Hypertension and Hypotension
Normal blood pressure is 120/80 mm Hg. Elevated blood pressure is 120-129/under 80 mm Hg. Hypertension, warranting treatment at 130/80 mm Hg, is often asymptomatic and can lead to severe cardiovascular events, aneurysms, peripheral arterial disease, chronic renal disease, or cardiac...
Cardiomyopathy V: Interprofessional Care
Cardiomyopathy III: Hypertrophic Cardiomyopathy

